<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Nephrol</journal-id><journal-id journal-id-type="publisher-id">WJN</journal-id><journal-title-group><journal-title>World Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2220-6124</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28948161</article-id><article-id pub-id-type="pmc">5592428</article-id><article-id pub-id-type="other">jWJN.v6.i5.pg236</article-id><article-id pub-id-type="doi">10.5527/wjn.v6.i5.236</article-id><article-categories><subj-group subj-group-type="heading"><subject>Observational Study</subject></subj-group></article-categories><title-group><article-title>Restless legs syndrome is contributing to fatigue and low quality of life levels in hemodialysis patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Giannaki</surname><given-names>Christoforos D</given-names></name><aff>Department of Life and Health Sciences, University of Nicosia, Nicosia CY 1700, Cyprus</aff><aff>the Cyprus Institute of Neurology and Genetics, Nicosia CY 1683, Cyprus. <email>giannaki.c@unic.ac.cy</email></aff></contrib><contrib contrib-type="author"><name><surname>Hadjigavriel</surname><given-names>Michael</given-names></name><aff>Hemodialysis Unit, Larnaca General Hospital, Larnaca CY 6021, Cyprus</aff></contrib><contrib contrib-type="author"><name><surname>Lazarou</surname><given-names>Akis</given-names></name><aff>Hemodialysis Unit, Limassol General Hospital, Limassol CY 3304, Cyprus</aff></contrib><contrib contrib-type="author"><name><surname>Michael</surname><given-names>Aristos</given-names></name><aff>Hemodialysis Unit, Limassol General Hospital, Limassol CY 3304, Cyprus</aff></contrib><contrib contrib-type="author"><name><surname>Damianou</surname><given-names>Loukas</given-names></name><aff>Hemodialysis Unit, Limassol General Hospital, Limassol CY 3304, Cyprus</aff></contrib><contrib contrib-type="author"><name><surname>Atmatzidis</surname><given-names>Efthimios</given-names></name><aff>Hemodialysis Unit, Limassol General Hospital, Limassol CY 3304, Cyprus</aff></contrib><contrib contrib-type="author"><name><surname>Stefanidis</surname><given-names>Ioannis</given-names></name><aff>School of Medicine, University of Thessaly, 41110 Larisa, Greece</aff></contrib><contrib contrib-type="author"><name><surname>Hadjigeorgiou</surname><given-names>Georgios M</given-names></name><aff>School of Medicine, University of Thessaly, 41110 Larisa, Greece</aff></contrib><contrib contrib-type="author"><name><surname>Sakkas</surname><given-names>Giorgos K</given-names></name><aff>Faculty of Sport and Health Sciences, University of St Mark and St John, Plymouth PL6 8BH, United Kingdom</aff></contrib><contrib contrib-type="author"><name><surname>Pantzaris</surname><given-names>Marios</given-names></name><aff>the Cyprus Institute of Neurology and Genetics, Nicosia CY 1683, Cyprus</aff></contrib></contrib-group><author-notes><fn><p>Author contributions: Giannaki CD substantial contributions to conception and design of the study, acquisition of data, analysis and interpretation of data; drafting the article, making critical revisions related to important intellectual content of the manuscript; and final approval of the version of the article to be published; Lazarou A, Atmatzidis E, Stefanidis I, Hadjigeorgiou GM and Sakkas GK substantial contributions to conception and design of the study, making critical revisions related to important intellectual content of the manuscript; final approval of the version of the article to be published; Hadjigavriel M, Michael A, Damianou L and Pantzaris M substantial contributions to conception and design of the study, acquisition of data; making critical revisions related to important intellectual content of the manuscript; final approval of the version of the article to be published.</p><p>Correspondence to: Christoforos D Giannaki, PhD, Department of Life and Health Sciences, University of Nicosia, 46 Makedonitisas Avenue, Nicosia CY 1700, Cyprus. <email>giannaki.c@unic.ac.cy</email></p><p>Telephone: +357-22-842325 Fax: +357-22-842399</p></fn></author-notes><pub-date pub-type="ppub"><day>6</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>6</day><month>9</month><year>2017</year></pub-date><volume>6</volume><issue>5</issue><fpage>236</fpage><lpage>242</lpage><history><date date-type="received"><day>28</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>20</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>7</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9;The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><abstract><sec><title>AIM</title><p>To examine whether hemodialysis (HD) patients with restless legs syndrome (RLS) are subjects of greater fatigue and impaired quality of life (QoL) compared to HD patients without RLS.</p></sec><sec><title>METHODS</title><p>Eighty five stable HD patients participated in this study. According to their RLS status, the patients were divided into the RLS group (<italic>n</italic> = 23) and the non-RLS group (<italic>n</italic> = 62). QoL, fatigue, sleep quality, daily sleepiness and depression symptoms were assessed by using various questionnaires. Finally, biochemical parameters including iron, ferritin, hemoglobin, hematocrit and parathormone were assessed.</p></sec><sec><title>RESULTS</title><p>The HD patients with RLS scored worse in all the questionnaires used in the study (<italic>P</italic> &#x0003c; 0.05). The patients with RLS were more likely to receive the HD therapy on the morning shift, whilst 43.5% of the RLS patients reported to experience the RLS symptoms also during HD. The severity of RLS was correlated with fatigue, depression score and sleep quality (<italic>P</italic> &#x0003c; 0.05).</p></sec><sec><title>CONCLUSION</title><p>HD patients with RLS are subject to lower QoL related parameters and greater fatigue compared to HD patients without RLS. RLS should be successfully managed in order to improve the QoL of the sufferers.</p></sec></abstract><kwd-group><kwd>Sleep quality</kwd><kwd>Depression</kwd><kwd>Secondary restless legs syndrome</kwd><kwd>Fatigue</kwd><kwd>Quality of life</kwd></kwd-group></article-meta></front><body><p><bold>Core tip:</bold> Restless legs syndrome (RLS) is very common in patients receiving hemodialysis therapy. It seems that the hemodialysis patients who suffer also from RLS are subject of greater fatigue levels and they are experience even more impaired quality of life, sleep quality, daily sleepiness and depression symptoms compared to their free RLS counterparts.</p><sec><title>INTRODUCTION</title><p>Restless legs syndrome (RLS) (also called as Willis-Ekbom disease) is a sensory-motor sleep disorder which is very common in hemodialysis (HD) patients. It is called also as uremic RLS and it is affecting almost 30% of the HD population[<xref rid="B1" ref-type="bibr">1</xref>].</p><p>According to the literature, the symptoms&#x02019; severity of uremic RLS is worse compared to the idiopathic RLS[<xref rid="B2" ref-type="bibr">2</xref>], whilst a number of studies highlight the negative effects of this extremely distressing sleep disorder on many aspects of the patient&#x02019;s quality of life (QoL), overall health and wellbeing[<xref rid="B1" ref-type="bibr">1</xref>].</p><p>In particular, data derived mainly from cross-sectional studies reveal that the HD patients with RLS experience significantly poorer sleep quality[<xref rid="B3" ref-type="bibr">3</xref>], increased insomnia[<xref rid="B4" ref-type="bibr">4</xref>] and motor activity during sleep[<xref rid="B5" ref-type="bibr">5</xref>], higher depression symptoms[<xref rid="B6" ref-type="bibr">6</xref>], increased anxiety levels[<xref rid="B7" ref-type="bibr">7</xref>] and increased muscle atrophy[<xref rid="B6" ref-type="bibr">6</xref>] compared to HD patients without RLS. Moreover, RLS motor and sensory symptoms may appear also during HD therapy[<xref rid="B8" ref-type="bibr">8</xref>] inducing significant disturbance of the patient&#x02019;s rest and patience. Therefore is not surprising that the HD patients with RLS are characterized by even poorer QoL levels compared to HD patients without RLS[<xref rid="B1" ref-type="bibr">1</xref>].</p><p>On the other hand, it is well known that the majority of the HD patients have significant levels of fatigue[<xref rid="B9" ref-type="bibr">9</xref>]. Fatigue experienced by the HD patients has both mental and physical aspects and could significantly affect the QoL levels of this specific population[<xref rid="B10" ref-type="bibr">10</xref>]. In the study by Jhamb et al[<xref rid="B11" ref-type="bibr">11</xref>], fatigue was independently associated, among others, with sleep quality and RLS.</p><p>The current study aimed to investigate potential differences in QoL, depression levels, sleep quality, fatigue and daily sleepiness status between HD patients with and without RLS. Taking into account the considerable negative effect of RLS on many physical and mental related parameters and especially on sleep, we hypothesize that the HD patients with RLS will present significantly greater fatigue and lower QoL levels compared to their free-RLS counterparts.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><p>Eighty-five out of 102 HD patients volunteer to participate in this study. Patients were recruited from the HD units of the General Hospitals of Larnaca and Limassol, Cyprus. After a brief discussion of the purpose of the study and the procedures to be followed, the patients who voluntarily agreed to participate to the study and gave written informed consent included in the cohort. Inclusion criteria were as follows: Being in HD therapy 3 times per week at least 3 mo and with stable clinical condition. Patients received the HD therapy with the morning shift either with the noon shift, both using hollow-fiber dialysers and bicarbonate buffer. Exclusion criteria included treatment with dopamine agonists prior to the study and cognitive inability to complete the various questionnaires.</p><p>RLS was diagnosed using the International RLS study group criteria[<xref rid="B12" ref-type="bibr">12</xref>], whilst RLS severity was assessed by using the International RLS Severity Scale (IRLS)[<xref rid="B13" ref-type="bibr">13</xref>]. Information related to when the first RLS symptoms appeared (before or after the institution of HD therapy), whether other members of the patients suffer also from RLS and whether the symptoms of RLS appear also during HD therapy were obtained also.</p><p>All patients provided a written consent for participation to the study, which conformed to the principles enumerated in the Helsinki Declaration of 1975. The study was approved by the National Bioethics Committee of Cyprus.</p><sec><title>Questionnaires</title><p>QoL levels were evaluated using the SF-36 questionnaire[<xref rid="B14" ref-type="bibr">14</xref>]. Fatigue levels were assessed by using the fatigue severity scale (FSS)[<xref rid="B15" ref-type="bibr">15</xref>]. The patients&#x02019; depression symptoms were assessed by using the self-rating depression scale developed by Zung[<xref rid="B16" ref-type="bibr">16</xref>]. Daily sleepiness status was assessed by using the Epworth Sleepiness Scale (ESS)[<xref rid="B17" ref-type="bibr">17</xref>]. Finally, the patients&#x02019; subjective sleep quality was assessed by the Pittsburgh sleep quality index (PSQI)[<xref rid="B18" ref-type="bibr">18</xref>].</p></sec><sec><title>Biochemical assessment</title><p>The patient&#x02019;s routine monthly laboratory results were recorded including iron (photometry), ferritin (spectophotometry, Beckman Coulter AU 680 Chemistry Analyzer), hematocrit, haemoglobin [sodium lauryl sulfate (SLS) method], albumin (photometry) and parathormone (chemiluminescence, ARCHITECT assay, Abbott Laboratories, Wiesbaden, Germany). The biochemical analysis was performed at the clinical labs of the affiliated hospitals under standard hospital procedures.</p></sec><sec><title>Statistical analysis</title><p>The differences between the RLS and the non-RLS group in regards to the various variables were examined using independent samples <italic>t</italic> test. <italic>&#x003c7;</italic><sup>2</sup> tests were used in order to compare the two groups for categorical variables. The Pearson correlation test was used to assess the relationship between the examined variables. All data are presented as mean &#x000b1; SD and the level of statistical significance was set at <italic>P</italic> &#x0003c; 0.05. All analyses were carried out using the SPSS Statistical Package version 19. The statistical review of the study was performed by a biomedical statistician.</p></sec></sec><sec><title>RESULTS</title><p>Twenty-three out of 84 patients (27%) were diagnosed to experience RLS symptoms, whilst 10 out of those 23 RLS patients reported to experience the RLS symptoms also during HD (43.5%). Only 2 patients reported that a member of their family experience also RLS symptoms (8.7%), whereas 3 patients reported to experience the RLS symptoms before the institution of the HD treatment (13%).</p><p>The patients&#x02019; characteristics are presented in Table <xref ref-type="table" rid="T1">1</xref>. The patients with RLS were found to have lower hemoglobin levels (<italic>P</italic> = 0.022) compared to the patients without RLS. In addition, the patients with RLS were more likely to receive the HD therapy on the morning shift (<italic>P</italic> = 0.026).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patient&#x02019;s characteristics presented as pool data and divided in two groups according to restless legs syndrome diagnosis</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Variables</bold></td><td rowspan="1" colspan="1"><bold>Patients pool data</bold></td><td rowspan="1" colspan="1"><bold>RLS</bold></td><td rowspan="1" colspan="1"><bold>Non-RLS</bold></td><td rowspan="1" colspan="1"><bold><italic>P</italic> value</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1"><italic>n</italic></td><td rowspan="1" colspan="1">85</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Female/male</td><td rowspan="1" colspan="1">54/31</td><td rowspan="1" colspan="1">10/13</td><td rowspan="1" colspan="1">21/41</td><td rowspan="1" colspan="1">0.414<xref ref-type="table-fn" rid="T1FN1">1</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Age (yr)</td><td rowspan="1" colspan="1">67.3 &#x000b1; 11.4</td><td rowspan="1" colspan="1">67.8 &#x000b1; 9.6</td><td rowspan="1" colspan="1">67.1 &#x000b1; 12.1</td><td rowspan="1" colspan="1">0.801</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">64.8 to 69.8</td><td rowspan="1" colspan="1">63.6 to 73.0</td><td rowspan="1" colspan="1">64.1 to 70.2</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td rowspan="1" colspan="1">73.3 &#x000b1; 15.9</td><td rowspan="1" colspan="1">77.3 &#x000b1; 20.4</td><td rowspan="1" colspan="1">72.0 &#x000b1; 14.1</td><td rowspan="1" colspan="1">0.205</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">67.5 to 87.2</td><td rowspan="1" colspan="1">68.3 to 75.7</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Dialysis shift morning/noon</td><td rowspan="1" colspan="1">54/31</td><td rowspan="1" colspan="1">4/19</td><td rowspan="1" colspan="1">35/27</td><td rowspan="1" colspan="1">0.026<xref ref-type="table-fn" rid="T1FN1">1</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Years in hemodialysis</td><td rowspan="1" colspan="1">4.7 &#x000b1; 5.1</td><td rowspan="1" colspan="1">5.2 &#x000b1; 4.9</td><td rowspan="1" colspan="1">4.5 &#x000b1; 5.2</td><td rowspan="1" colspan="1">0.592</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">3.6 to 5.8</td><td rowspan="1" colspan="1">3.1 to 7.3</td><td rowspan="1" colspan="1">3.2 to 5.9</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IRLS score</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">21.8 &#x000b1; 6.1</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">19.1 to 24.5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Iron (&#x003bc;g/dL)</td><td rowspan="1" colspan="1">44.7 &#x000b1; 18.2</td><td rowspan="1" colspan="1">43.0 &#x000b1; 16.6</td><td rowspan="1" colspan="1">45.4 &#x000b1; 19.0</td><td rowspan="1" colspan="1">0.741</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">38.2 to 51.2</td><td rowspan="1" colspan="1">30.2 to 55.7</td><td rowspan="1" colspan="1">37.3 to 53.4</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ferritin (ng/mL)</td><td rowspan="1" colspan="1">514.4 &#x000b1; 411.7</td><td rowspan="1" colspan="1">443.7 &#x000b1; 356.5</td><td rowspan="1" colspan="1">547.4 &#x000b1; 441.5</td><td rowspan="1" colspan="1">0.567</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">344.4 to 684.3</td><td rowspan="1" colspan="1">145.6 to 741.8</td><td rowspan="1" colspan="1">320.4 to 774.6</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hct</td><td rowspan="1" colspan="1">36.4 &#x000b1; 5.3</td><td rowspan="1" colspan="1">33.9 &#x000b1; 5.6</td><td rowspan="1" colspan="1">37.7 &#x000b1; 4.9</td><td rowspan="1" colspan="1">0.111</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">34.2 to 38.7</td><td rowspan="1" colspan="1">29.2 to 38.7</td><td rowspan="1" colspan="1">35.1 to 40.3</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hb (g/dL)</td><td rowspan="1" colspan="1">11.1 &#x000b1; 1.5</td><td rowspan="1" colspan="1">10.1 &#x000b1; 1.6</td><td rowspan="1" colspan="1">11.4 &#x000b1; 1.4</td><td rowspan="1" colspan="1">0.022</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">10.5 to 11.6</td><td rowspan="1" colspan="1">8.9 to 11.3</td><td rowspan="1" colspan="1">10.8 to 12.0</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Parathormone (pmol/L)</td><td rowspan="1" colspan="1">4.9 &#x000b1; 1.9</td><td rowspan="1" colspan="1">4.8 &#x000b1; 1.7</td><td rowspan="1" colspan="1">4.9 &#x000b1; 2.0</td><td rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">4.2 to 5.5</td><td rowspan="1" colspan="1">3.6 to 6.1</td><td rowspan="1" colspan="1">4.0 to 5.8</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Albumin (g/dL)</td><td rowspan="1" colspan="1">3.6 &#x000b1; 0.3</td><td rowspan="1" colspan="1">3.6 &#x000b1; 0.3</td><td rowspan="1" colspan="1">3.6 &#x000b1; 0.3</td><td rowspan="1" colspan="1">0.853</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">3.5 to 3.8</td><td rowspan="1" colspan="1">3.4 to 3.9</td><td rowspan="1" colspan="1">3.5 to 3.8</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes (%)</td><td rowspan="1" colspan="1">30 (35.3)</td><td rowspan="1" colspan="1">9 (39.1)</td><td rowspan="1" colspan="1">21 (33.9)</td><td rowspan="1" colspan="1">0.765<xref ref-type="table-fn" rid="T1FN1">1</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension (%)</td><td rowspan="1" colspan="1">30 (35.3 )</td><td rowspan="1" colspan="1">8 (34.8)</td><td rowspan="1" colspan="1">22 (35.5)</td><td rowspan="1" colspan="1">0.832<xref ref-type="table-fn" rid="T1FN1">1</xref></td></tr></tbody></table><table-wrap-foot><fn id="T1FN1"><label>1</label><p>For categorical data a <italic>&#x003c7;</italic><sup>2</sup> test performed. All data are mean &#x000b1; SD (95%CI). IRLS: International restless legs syndrome severity scale; Hct: Hematocrit; Hb: Hemoglobin.</p></fn></table-wrap-foot></table-wrap><p>Depression, fatigue, daytime sleepiness and sleep quality data are presented in Table <xref ref-type="table" rid="T2">2</xref>. QoL data are presented in Table <xref ref-type="table" rid="T3">3</xref>. All the examined parameters were found to be significantly worse in the RLS patients compared to the free-RLS patients (<italic>P</italic> &#x0003c; 0.05). Finally, the IRLS score positively correlated with PSQI (<italic>r</italic> = 0.477, <italic>P</italic> = 0.025), depression score (<italic>r</italic> = 0.551, <italic>P</italic> = 0.010) and fatigue index (<italic>r</italic> = 0.582, <italic>P</italic> = 0.004).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Depression, fatigue, daytime sleepiness and sleep quality data presented as pool data and divided in two groups according to restless legs syndrome diagnosis</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Variables</bold></td><td rowspan="1" colspan="1"><bold>Patients pool data</bold></td><td rowspan="1" colspan="1"><bold>RLS</bold></td><td rowspan="1" colspan="1"><bold>Non-RLS</bold></td><td rowspan="1" colspan="1"><bold><italic>P</italic> value</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Pittsburgh sleep quality index</td><td rowspan="1" colspan="1">7.8 &#x000b1; 5.1</td><td rowspan="1" colspan="1">13.9 &#x000b1; 2.9</td><td rowspan="1" colspan="1">5.5 &#x000b1; 3.6</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">6.6 to 7.9</td><td rowspan="1" colspan="1">12.6 to 15.2</td><td rowspan="1" colspan="1">4.6 to 6.5</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Epworth sleepiness scale</td><td rowspan="1" colspan="1">4.3 &#x000b1; 3.6</td><td rowspan="1" colspan="1">6.8 &#x000b1; 4.3</td><td rowspan="1" colspan="1">3.4 &#x000b1; 2.8</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">3.5 to 5.1</td><td rowspan="1" colspan="1">4.9 to 8.7</td><td rowspan="1" colspan="1">2.6 to 4.1</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Zung depression scale</td><td rowspan="1" colspan="1">60.8 &#x000b1; 7.1</td><td rowspan="1" colspan="1">58.0 &#x000b1; 4.0</td><td rowspan="1" colspan="1">48.3 &#x000b1; 6.1</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">49.2 to 52.4</td><td rowspan="1" colspan="1">56.1 to 59.8</td><td rowspan="1" colspan="1">46.7 to 49.9</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Fatigue severity scale index</td><td rowspan="1" colspan="1">4.5 &#x000b1; 1.2</td><td rowspan="1" colspan="1">5.8 &#x000b1; 0.7</td><td rowspan="1" colspan="1">4.1 &#x000b1; 1.1</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">4.3 to 4.8</td><td rowspan="1" colspan="1">5.4 to 6.1</td><td rowspan="1" colspan="1">3.8 to 4.3</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>All data are mean &#x000b1; SD (95%CI). RLS: Restless legs syndrome.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Quality of life data presented as pool data and divided in two groups according to restless legs syndrome diagnosis</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Variables</bold></td><td rowspan="1" colspan="1"><bold>Patients pool data</bold></td><td rowspan="1" colspan="1"><bold>RLS</bold></td><td rowspan="1" colspan="1"><bold>Non-RLS</bold></td><td rowspan="1" colspan="1"><bold><italic>P</italic> value</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">SF-36 MCS</td><td rowspan="1" colspan="1">55.3 &#x000b1; 16.7</td><td rowspan="1" colspan="1">46.6 &#x000b1; 15.4</td><td rowspan="1" colspan="1">58.5 &#x000b1; 16.1</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">51.6 to 59.0</td><td rowspan="1" colspan="1">39.8 to 53.5</td><td rowspan="1" colspan="1">54.3 to 62.7</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SF-36 PCS</td><td rowspan="1" colspan="1">51.8 &#x000b1; 19.4</td><td rowspan="1" colspan="1">40.6 &#x000b1; 18.1</td><td rowspan="1" colspan="1">56.1 &#x000b1; 18.2</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">47.5 to 56.1</td><td rowspan="1" colspan="1">32.5 to 48.6</td><td rowspan="1" colspan="1">51.2 to 60.8</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SF-36 total score</td><td rowspan="1" colspan="1">55.1 &#x000b1; 18.8</td><td rowspan="1" colspan="1">45.5 &#x000b1; 17.7</td><td rowspan="1" colspan="1">58.7 &#x000b1; 18.1</td><td rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">51.0 to 59.3</td><td rowspan="1" colspan="1">37.6 to 53.3</td><td rowspan="1" colspan="1">54.0 to 63.4</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Physical function</td><td rowspan="1" colspan="1">46.9 &#x000b1; 29.1</td><td rowspan="1" colspan="1">38.4 &#x000b1; 28.2</td><td rowspan="1" colspan="1">50.1 &#x000b1; 29.1</td><td rowspan="1" colspan="1">0.107</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">40.5 to 53.4</td><td rowspan="1" colspan="1">25.8 to 50.9</td><td rowspan="1" colspan="1">42.5 to 57.7</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Role physical</td><td rowspan="1" colspan="1">45.3 &#x000b1; 42.4</td><td rowspan="1" colspan="1">28.4 &#x000b1; 38.8</td><td rowspan="1" colspan="1">51.6 &#x000b1; 42.2</td><td rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">35.9 to 54.7</td><td rowspan="1" colspan="1">11.2 to 45.6</td><td rowspan="1" colspan="1">40.6 to 42.7</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Body pain</td><td rowspan="1" colspan="1">72.3 &#x000b1; 23.1</td><td rowspan="1" colspan="1">63.9 &#x000b1; 24.3</td><td rowspan="1" colspan="1">75.4 &#x000b1; 22.0</td><td rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">67.1 to 77.4</td><td rowspan="1" colspan="1">53.1 to 74.7</td><td rowspan="1" colspan="1">69.6 to 81.1</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">General health</td><td rowspan="1" colspan="1">47.0 &#x000b1; 16.4</td><td rowspan="1" colspan="1">37.1 &#x000b1; 14.5</td><td rowspan="1" colspan="1">50.7 &#x000b1; 15.6</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">43.4 to 50.6</td><td rowspan="1" colspan="1">30.6 to 43.5</td><td rowspan="1" colspan="1">46.6 to 54.8</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vitality</td><td rowspan="1" colspan="1">48.3 &#x000b1; 16.1</td><td rowspan="1" colspan="1">36.1 &#x000b1; 14.5</td><td rowspan="1" colspan="1">52.8 &#x000b1; 14.2</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">44.7 to 51.8</td><td rowspan="1" colspan="1">29.6 to 42.5</td><td rowspan="1" colspan="1">49.1 to 56.6</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Social functioning</td><td rowspan="1" colspan="1">71.8 &#x000b1; 20.8</td><td rowspan="1" colspan="1">65.5 &#x000b1; 21.7</td><td rowspan="1" colspan="1">74.1 &#x000b1; 20.2</td><td rowspan="1" colspan="1">0.098</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">67.2 to 76.4</td><td rowspan="1" colspan="1">55.9 to 75.1</td><td rowspan="1" colspan="1">68.9 to 79.4</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mental health</td><td rowspan="1" colspan="1">52.2 &#x000b1; 45.3</td><td rowspan="1" colspan="1">43.9 &#x000b1; 47.5</td><td rowspan="1" colspan="1">55.3 &#x000b1; 44.4</td><td rowspan="1" colspan="1">0.316</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">42.2 to 62.3</td><td rowspan="1" colspan="1">22.8 to 65.0</td><td rowspan="1" colspan="1">43.7 to 66.9</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Reported health</td><td rowspan="1" colspan="1">57.1 &#x000b1; 12.1</td><td rowspan="1" colspan="1">50.7 &#x000b1; 10.7</td><td rowspan="1" colspan="1">59.5 &#x000b1; 11.8</td><td rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">95%CI</td><td rowspan="1" colspan="1">54.4 to 59.8</td><td rowspan="1" colspan="1">45.9 to 55.4</td><td rowspan="1" colspan="1">56.4 to 62.6</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>All data are mean &#x000b1; SD (95%CI). SF-36: 36-Item Short Form Health Survey; MCS: Mental component score; PCS: Physical component score; RLS: Restless legs syndrome.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>DISCUSSION</title><p>The main finding of the current study is that the HD patients who suffer also from RLS are subject of greater fatigue levels and they are experience even more impaired QoL, sleep quality, daily sleepiness and depression symptoms compared to HD patients without RLS.</p><p>Many factors could contribute to the increased fatigue levels of the HD patients. Recent studies indicate sleep disorders as one of the major factors which may be responsible for the elevated fatigue levels of the HD patients[<xref rid="B10" ref-type="bibr">10</xref>]. Interestingly, in line with our findings, RLS has been reported to associate with greater fatigue levels in patients on HD[<xref rid="B11" ref-type="bibr">11</xref>].</p><p>RLS is a sleep disorder which is highly prevalent in the HD population[<xref rid="B1" ref-type="bibr">1</xref>]. Approximately 27% of the studied patients were diagnosed to experience RLS symptoms; a prevalence which is in line with the published literature in the field[<xref rid="B1" ref-type="bibr">1</xref>]. We should note that those are the first data regarding RLS from Cyprus. In addition, approximately 43.5% of the RLS patients reported to experience the RLS symptoms during HD therapy, factor that may contribute to increase fatigability of the patients during their treatment. On the other hand, the findings of the current study reveal that the patients with RLS have significantly worse daily sleepiness status, in line with previous findings[<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B19" ref-type="bibr">19</xref>]. Daily sleepiness has been shown to be associated with fatigue in patients receiving HD therapy[<xref rid="B11" ref-type="bibr">11</xref>]. Finally, the data of the current study confirm the well known negative effect of uremic RLS on sleep quality[<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B4" ref-type="bibr">4</xref>], whilst the severity of RLS was correlated with poor sleep quality.</p><p>Taking into consideration the fact that many HD patients experience elevated fatigue symptoms[<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B20" ref-type="bibr">20</xref>] and the fact that RLS may contribute to even greater fatigue symptoms, successful management of RLS may help those patients to reduce among others also fatigue and tiredness feelings. It is known that exercise training alone[<xref rid="B21" ref-type="bibr">21</xref>-<xref rid="B23" ref-type="bibr">23</xref>] or in combination with dopamine agonists[<xref rid="B24" ref-type="bibr">24</xref>] could ameliorate the severity of uremic RLS symptoms. On the other hand, evidence exists regarding the favorable effect of exercise training on fatigue levels of HD patients, however, RLS presence was not taken into consideration in these studies[<xref rid="B20" ref-type="bibr">20</xref>]. It would be interesting in future studies to investigate the effects of chronic exercise training on fatigue levels in patients with uremic RLS.</p><p>Morning-shift HD was found to associated with RLS, in contrast with previous studies[<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>], however, we should note that the association between the time of HD delivery and RLS is still controversial. In addition, hemoglobin levels observed to be significantly lower in the RLS group, confirming previous data[<xref rid="B27" ref-type="bibr">27</xref>]. Notably, low haemoglobin levels may contribute to greater levels of fatigue in the HD population[<xref rid="B28" ref-type="bibr">28</xref>]. However, we should note that many cross-sectional studies did not confirm an association between lower hemoglobin levels and RLS presence in HD patients[<xref rid="B6" ref-type="bibr">6</xref>].</p><p>According to the literature, familiar component appear to be high in idiopathic RLS[<xref rid="B29" ref-type="bibr">29</xref>]. In contrast, familial component reported to be significantly lower in patients with uremic RLS compared to idiopathic RLS[<xref rid="B30" ref-type="bibr">30</xref>]. In the current study, approximately 9% of the RLS patients reported that a member of their family experience also RLS symptoms, in line with previous data which reported similar prevalence[<xref rid="B30" ref-type="bibr">30</xref>]. In addition, 13% of the RLS patients reported that they were experience the RLS symptoms before the start of the HD treatment, showing the association of renal disease and RLS. Interestingly, the RLS symptoms have been reported to ameliorated or disappeared after kidney transplantation[<xref rid="B31" ref-type="bibr">31</xref>]. Moreover, no gender differences were found in regards to the RLS presence in our study, confirming previous studies[<xref rid="B32" ref-type="bibr">32</xref>], and in contrast to others[<xref rid="B27" ref-type="bibr">27</xref>].</p><p>Diabetes prevalence did not differ between groups. It is known that RLS has been linked to various diseases, including diabetes and hypertension[<xref rid="B33" ref-type="bibr">33</xref>]. In the current study no such an association was found between RLS presence and diabetes and hypertension presence.</p><p>Depression score was found to be significantly worse in the patients with RLS compared to the patients without RLS, confirming previous studies the RLS group[<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B34" ref-type="bibr">34</xref>]. Moreover, depression score was correlated with the severity of RLS. The depressing effect of RLS on various parameters which are known to affect fatigue levels in HD patients such as sleep, QoL and depression[<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B35" ref-type="bibr">35</xref>] and the distressful nature of the syndrome itself may explain the higher depression score of the patients of the RLS group.</p><p>In conclusion, the findings of the current study confirm the negative effect of RLS on many aspects of QoL, including greater fatigue levels. Measures should be taken in order to manage the RLS symptoms and improve the QoL and general health of the patients with uremic RLS.</p></sec><sec><title>ACKNOWLEDGMENTS</title><p>We would like to thank all hemodialysis patients who volunteered for the purposes of this study, as well as the staff at the hemodialysis unit of Limassol General Hospital and Larnaca General Hospital, Cyprus, for their expert advice and valuable help.</p></sec><sec><title>COMMENTS</title><sec><title>Background</title><p>Restless legs syndrome (RLS) (also called as Willis-Ekbom disease) is a sensory-motor sleep disorder which is very common in hemodialysis patients. Evidence reveals that RLS negatively affects various aspects of health and quality of life (QoL) in patients receiving hemodialysis (HD) therapy.</p></sec><sec><title>Research frontiers</title><p>It is well known that fatigue is one of the most common symptoms experienced by hemodialysis patients. However, it is not clear whether the hemodialysis patients who suffer also from RLS are subjects of greater fatigue levels compared to their free-RLS counterparts.</p></sec><sec><title>Innovations and breakthroughs</title><p>The main finding of the current study is that the hemodialysis patients who suffer also from RLS are subject of greater fatigue levels and they are experience even more impaired QoL, sleep quality, daily sleepiness and depression symptoms compared to hemodialysis patients without RLS. Those are the first published data regarding uremic RLS from Cyprus.</p></sec><sec><title>Applications</title><p>RLS could induce further impairments on various QoL and overall health parameters in patients receiving hemodialysis therapy. Given that almost 30% of the hemodialysis patients suffer from RLS, measures should be taken (pharmacological or non-pharmacological) in order to ameliorate the RLS symptoms and improve QoL and overall health of the hemodialysis patients.</p></sec><sec><title>Terminology</title><p>RLS characterized by an irresistible need to move the legs, usually accompanied by unpleasant sensations. The symptoms of RLS begin or worsen during periods of rest and inactivity (usually at night) resulting in a significant sleep disturbance. The urge to move or unpleasant sensations are partially or totally relieved by movement at least as long as the activity continues.</p></sec><sec><title>Peer-review</title><p>The paper is well-written.</p></sec></sec></body><back><fn-group><fn><p>Institutional review board statement: This study was approved by the National Bioethics Committee of Cyprus (no. EE&#x00392;&#x0039a; &#x00395;&#x003a0;/2012.01.74).</p></fn><fn><p>Informed consent statement: All study participants providec informed written consent prior to study enrollment.</p></fn><fn fn-type="COI-statement"><p>Conflict-of-interest statement: None.</p></fn><fn><p>Data sharing statement: No additinal data are available.</p></fn><fn><p>Manuscript source: Invited manuscript</p></fn><fn><p>Specialty type: Urology and nephrology</p></fn><fn><p>Country of origin: United Kingdom</p></fn><fn><p>Peer-review report classification</p></fn><fn><p>Grade A (Excellent): 0</p></fn><fn><p>Grade B (Very good): 0</p></fn><fn><p>Grade C (Good): C, C</p></fn><fn><p>Grade D (Fair): 0</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn><p>Peer-review started: February 12, 2017</p></fn><fn><p>First decision: April 18, 2017</p></fn><fn><p>Article in press: July 9, 2017</p></fn><fn><p>P- Reviewer: Taheri S, Watanabe T S- Editor: Ji FF L- Editor: A E- Editor: Lu YJ</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Pantzaris</surname><given-names>MC</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name><name><surname>Sakkas</surname><given-names>GK</given-names></name></person-group><article-title>Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review</article-title><source>Kidney Int</source><year>2014</year><volume>85</volume><fpage>1275</fpage><lpage>1282</lpage><pub-id pub-id-type="pmid">24107848</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gkizlis</surname><given-names>V</given-names></name><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Mihas</surname><given-names>C</given-names></name><name><surname>Koutedakis</surname><given-names>Y</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name><name><surname>Sakkas</surname><given-names>GK</given-names></name></person-group><article-title>Uremic versus idiopathic restless legs syndrome: impact on aspects related to quality of life</article-title><source>ASAIO J</source><year>2012</year><volume>58</volume><fpage>607</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">23069899</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gade</surname><given-names>K</given-names></name><name><surname>Blaschke</surname><given-names>S</given-names></name><name><surname>Rodenbeck</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Anderson-Schmidt</surname><given-names>H</given-names></name><name><surname>Cohrs</surname><given-names>S</given-names></name></person-group><article-title>Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone</article-title><source>Kidney Blood Press Res</source><year>2013</year><volume>37</volume><fpage>458</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">24247595</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mucsi</surname><given-names>I</given-names></name><name><surname>Molnar</surname><given-names>MZ</given-names></name><name><surname>Ambrus</surname><given-names>C</given-names></name><name><surname>Szeifert</surname><given-names>L</given-names></name><name><surname>Kovacs</surname><given-names>AZ</given-names></name><name><surname>Zoller</surname><given-names>R</given-names></name><name><surname>Bar&#x000f3;tfi</surname><given-names>S</given-names></name><name><surname>Remport</surname><given-names>A</given-names></name><name><surname>Novak</surname><given-names>M</given-names></name></person-group><article-title>Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis</article-title><source>Nephrol Dial Transplant</source><year>2005</year><volume>20</volume><fpage>571</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">15671074</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name><name><surname>Namba</surname><given-names>K</given-names></name><name><surname>Munezawa</surname><given-names>T</given-names></name><name><surname>Matsuura</surname><given-names>M</given-names></name></person-group><article-title>Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients</article-title><source>Mov Disord</source><year>2008</year><volume>23</volume><fpage>811</fpage><lpage>816; quiz 926</lpage><pub-id pub-id-type="pmid">18074382</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Sakkas</surname><given-names>GK</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Lavdas</surname><given-names>E</given-names></name><name><surname>Liakopoulos</surname><given-names>V</given-names></name><name><surname>Tsianas</surname><given-names>N</given-names></name><name><surname>Koukoulis</surname><given-names>GN</given-names></name><name><surname>Koutedakis</surname><given-names>Y</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name></person-group><article-title>Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e25180</fpage><pub-id pub-id-type="pmid">21984901</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikici</surname><given-names>S</given-names></name><name><surname>Bahadir</surname><given-names>A</given-names></name><name><surname>Baltaci</surname><given-names>D</given-names></name><name><surname>Ankarali</surname><given-names>H</given-names></name><name><surname>Eroglu</surname><given-names>M</given-names></name><name><surname>Ercan</surname><given-names>N</given-names></name><name><surname>Sav</surname><given-names>T</given-names></name></person-group><article-title>Association of anxiety, sleepiness, and sexual dysfunction with restless legs syndrome in hemodialysis patients</article-title><source>Hemodial Int</source><year>2014</year><volume>18</volume><fpage>809</fpage><lpage>818</lpage><pub-id pub-id-type="pmid">24865547</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Sakkas</surname><given-names>GK</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Patramani</surname><given-names>G</given-names></name><name><surname>Lavdas</surname><given-names>E</given-names></name><name><surname>Liakopoulos</surname><given-names>V</given-names></name><name><surname>Koutedakis</surname><given-names>Y</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name></person-group><article-title>Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome</article-title><source>ASAIO J</source><year>2010</year><volume>56</volume><fpage>538</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">21245801</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisbord</surname><given-names>SD</given-names></name><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Arnold</surname><given-names>RM</given-names></name><name><surname>Fine</surname><given-names>MJ</given-names></name><name><surname>Levenson</surname><given-names>DJ</given-names></name><name><surname>Peterson</surname><given-names>RA</given-names></name><name><surname>Switzer</surname><given-names>GE</given-names></name></person-group><article-title>Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><fpage>2487</fpage><lpage>2494</lpage><pub-id pub-id-type="pmid">15975996</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakkas</surname><given-names>GK</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name></person-group><article-title>Hemodialysis fatigue: just &#x0201c;simple&#x0201d; fatigue or a syndrome on its own right?</article-title><source>Front Physiol</source><year>2012</year><volume>3</volume><fpage>306</fpage><pub-id pub-id-type="pmid">22934057</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhamb</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>K</given-names></name><name><surname>Yabes</surname><given-names>J</given-names></name><name><surname>Steel</surname><given-names>JL</given-names></name><name><surname>Dew</surname><given-names>MA</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Unruh</surname><given-names>M</given-names></name></person-group><article-title>Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue?</article-title><source>Am J Nephrol</source><year>2013</year><volume>38</volume><fpage>489</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">24335380</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>RP</given-names></name><name><surname>Picchietti</surname><given-names>DL</given-names></name><name><surname>Garcia-Borreguero</surname><given-names>D</given-names></name><name><surname>Ondo</surname><given-names>WG</given-names></name><name><surname>Walters</surname><given-names>AS</given-names></name><name><surname>Winkelman</surname><given-names>JW</given-names></name><name><surname>Zucconi</surname><given-names>M</given-names></name><name><surname>Ferri</surname><given-names>R</given-names></name><name><surname>Trenkwalder</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>HB</given-names></name></person-group><article-title>Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance</article-title><source>Sleep Med</source><year>2014</year><volume>15</volume><fpage>860</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">25023924</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walters</surname><given-names>AS</given-names></name><name><surname>LeBrocq</surname><given-names>C</given-names></name><name><surname>Dhar</surname><given-names>A</given-names></name><name><surname>Hening</surname><given-names>W</given-names></name><name><surname>Rosen</surname><given-names>R</given-names></name><name><surname>Allen</surname><given-names>RP</given-names></name><name><surname>Trenkwalder</surname><given-names>C</given-names></name></person-group><article-title>Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome</article-title><source>Sleep Med</source><year>2003</year><volume>4</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">14592342</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>JE</given-names></name></person-group><article-title>SF-36 health survey update</article-title><source>Spine (Phila Pa 1976)</source><year>2000</year><volume>25</volume><fpage>3130</fpage><lpage>3139</lpage><pub-id pub-id-type="pmid">11124729</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krupp</surname><given-names>LB</given-names></name><name><surname>LaRocca</surname><given-names>NG</given-names></name><name><surname>Muir-Nash</surname><given-names>J</given-names></name><name><surname>Steinberg</surname><given-names>AD</given-names></name></person-group><article-title>The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus</article-title><source>Arch Neurol</source><year>1989</year><volume>46</volume><fpage>1121</fpage><lpage>1123</lpage><pub-id pub-id-type="pmid">2803071</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zung</surname><given-names>WW</given-names></name></person-group><article-title>A self-rating depression scale</article-title><source>Arch Gen Psychiatry</source><year>1965</year><volume>12</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">14221692</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johns</surname><given-names>MW</given-names></name></person-group><article-title>A new method for measuring daytime sleepiness: the Epworth sleepiness scale</article-title><source>Sleep</source><year>1991</year><volume>14</volume><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">1798888</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buysse</surname><given-names>DJ</given-names></name><name><surname>Reynolds</surname><given-names>CF</given-names></name><name><surname>Monk</surname><given-names>TH</given-names></name><name><surname>Berman</surname><given-names>SR</given-names></name><name><surname>Kupfer</surname><given-names>DJ</given-names></name></person-group><article-title>The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research</article-title><source>Psychiatry Res</source><year>1989</year><volume>28</volume><fpage>193</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">2748771</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Jahdali</surname><given-names>HH</given-names></name><name><surname>Al-Qadhi</surname><given-names>WA</given-names></name><name><surname>Khogeer</surname><given-names>HA</given-names></name><name><surname>Al-Hejaili</surname><given-names>FF</given-names></name><name><surname>Al-Ghamdi</surname><given-names>SM</given-names></name><name><surname>Al Sayyari</surname><given-names>AA</given-names></name></person-group><article-title>Restless legs syndrome in patients on dialysis</article-title><source>Saudi J Kidney Dis Transpl</source><year>2009</year><volume>20</volume><fpage>378</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">19414938</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossola</surname><given-names>M</given-names></name><name><surname>Vulpio</surname><given-names>C</given-names></name><name><surname>Tazza</surname><given-names>L</given-names></name></person-group><article-title>Fatigue in chronic dialysis patients</article-title><source>Semin Dial</source><year>2011</year><volume>24</volume><fpage>550</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">21917000</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Sakkas</surname><given-names>GK</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Lavdas</surname><given-names>E</given-names></name><name><surname>Kyriakides</surname><given-names>T</given-names></name><name><surname>Koutedakis</surname><given-names>Y</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name></person-group><article-title>Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study</article-title><source>BMC Nephrol</source><year>2013</year><volume>14</volume><fpage>194</fpage><pub-id pub-id-type="pmid">24024727</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Maridaki</surname><given-names>MD</given-names></name><name><surname>Koutedakis</surname><given-names>Y</given-names></name><name><surname>Founta</surname><given-names>P</given-names></name><name><surname>Tsianas</surname><given-names>N</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name><name><surname>Sakkas</surname><given-names>GK</given-names></name></person-group><article-title>A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome</article-title><source>Nephrol Dial Transplant</source><year>2013</year><volume>28</volume><fpage>2834</fpage><lpage>2840</lpage><pub-id pub-id-type="pmid">23929523</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakkas</surname><given-names>GK</given-names></name><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Maridaki</surname><given-names>M</given-names></name><name><surname>Koutedakis</surname><given-names>Y</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name></person-group><article-title>Current trends in the management of uremic restless legs syndrome: a systematic review on aspects related to quality of life, cardiovascular mortality and survival</article-title><source>Sleep Med Rev</source><year>2015</year><volume>21</volume><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">25261116</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannaki</surname><given-names>CD</given-names></name><name><surname>Sakkas</surname><given-names>GK</given-names></name><name><surname>Karatzaferi</surname><given-names>C</given-names></name><name><surname>Maridaki</surname><given-names>MD</given-names></name><name><surname>Koutedakis</surname><given-names>Y</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>GM</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name></person-group><article-title>Combination of Exercise Training and Dopamine Agonists in Patients with RLS on Dialysis: A Randomized, Double-Blind Placebo-Controlled Study</article-title><source>ASAIO J</source><year>2015</year><volume>61</volume><fpage>738</fpage><lpage>741</lpage><pub-id pub-id-type="pmid">26262586</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastos</surname><given-names>JP</given-names></name><name><surname>Sousa</surname><given-names>RB</given-names></name><name><surname>Nepomuceno</surname><given-names>LA</given-names></name><name><surname>Gutierrez-Adrianzen</surname><given-names>OA</given-names></name><name><surname>Bruin</surname><given-names>PF</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>ML</given-names></name><name><surname>Bruin</surname><given-names>VM</given-names></name></person-group><article-title>Sleep disturbances in patients on maintenance hemodialysis: role of dialysis shift</article-title><source>Rev Assoc Med Bras (1992)</source><year>2007</year><volume>53</volume><fpage>492</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">18157361</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutner</surname><given-names>NG</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Szczech</surname><given-names>LA</given-names></name><name><surname>Bliwise</surname><given-names>DL</given-names></name></person-group><article-title>Restless legs syndrome reported by incident haemodialysis patients: is treatment time of day relevant?</article-title><source>Nephrology (Carlton)</source><year>2012</year><volume>17</volume><fpage>783</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">22713094</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>SM</given-names></name><name><surname>de Bruin</surname><given-names>VM</given-names></name><name><surname>Nepomuceno</surname><given-names>LA</given-names></name><name><surname>Maximo</surname><given-names>ML</given-names></name><name><surname>Daher Ede</surname><given-names>F</given-names></name><name><surname>Correia Ferrer</surname><given-names>DP</given-names></name><name><surname>de Bruin</surname><given-names>PF</given-names></name></person-group><article-title>Restless legs syndrome in end-stage renal disease: Clinical characteristics and associated comorbidities</article-title><source>Sleep Med</source><year>2010</year><volume>11</volume><fpage>785</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">20667773</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhamb</surname><given-names>M</given-names></name><name><surname>Weisbord</surname><given-names>SD</given-names></name><name><surname>Steel</surname><given-names>JL</given-names></name><name><surname>Unruh</surname><given-names>M</given-names></name></person-group><article-title>Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors</article-title><source>Am J Kidney Dis</source><year>2008</year><volume>52</volume><fpage>353</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">18572290</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkelmann</surname><given-names>J</given-names></name><name><surname>Polo</surname><given-names>O</given-names></name><name><surname>Provini</surname><given-names>F</given-names></name><name><surname>Nevsimalova</surname><given-names>S</given-names></name><name><surname>Kemlink</surname><given-names>D</given-names></name><name><surname>Sonka</surname><given-names>K</given-names></name><name><surname>H&#x000f6;gl</surname><given-names>B</given-names></name><name><surname>Poewe</surname><given-names>W</given-names></name><name><surname>Stiasny-Kolster</surname><given-names>K</given-names></name><name><surname>Oertel</surname><given-names>W</given-names></name><etal/></person-group><article-title>Genetics of restless legs syndrome (RLS): State-of-the-art and future directions</article-title><source>Mov Disord</source><year>2007</year><volume>22 Suppl 18</volume><fpage>S449</fpage><lpage>S458</lpage><pub-id pub-id-type="pmid">17557342</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkelmann</surname><given-names>J</given-names></name><name><surname>Wetter</surname><given-names>TC</given-names></name><name><surname>Collado-Seidel</surname><given-names>V</given-names></name><name><surname>Gasser</surname><given-names>T</given-names></name><name><surname>Dichgans</surname><given-names>M</given-names></name><name><surname>Yassouridis</surname><given-names>A</given-names></name><name><surname>Trenkwalder</surname><given-names>C</given-names></name></person-group><article-title>Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients</article-title><source>Sleep</source><year>2000</year><volume>23</volume><fpage>597</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">10947027</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkelmann</surname><given-names>J</given-names></name><name><surname>Stautner</surname><given-names>A</given-names></name><name><surname>Samtleben</surname><given-names>W</given-names></name><name><surname>Trenkwalder</surname><given-names>C</given-names></name></person-group><article-title>Long-term course of restless legs syndrome in dialysis patients after kidney transplantation</article-title><source>Mov Disord</source><year>2002</year><volume>17</volume><fpage>1072</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">12360562</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aritake-Okada</surname><given-names>S</given-names></name><name><surname>Nakao</surname><given-names>T</given-names></name><name><surname>Komada</surname><given-names>Y</given-names></name><name><surname>Asaoka</surname><given-names>S</given-names></name><name><surname>Sakuta</surname><given-names>K</given-names></name><name><surname>Esaki</surname><given-names>S</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Nakashima</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name></person-group><article-title>Prevalence and clinical characteristics of restless legs syndrome in chronic kidney disease patients</article-title><source>Sleep Med</source><year>2011</year><volume>12</volume><fpage>1031</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">22036105</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trenkwalder</surname><given-names>C</given-names></name><name><surname>Allen</surname><given-names>R</given-names></name><name><surname>H&#x000f6;gl</surname><given-names>B</given-names></name><name><surname>Paulus</surname><given-names>W</given-names></name><name><surname>Winkelmann</surname><given-names>J</given-names></name></person-group><article-title>Restless legs syndrome associated with major diseases: A systematic review and new concept</article-title><source>Neurology</source><year>2016</year><volume>86</volume><fpage>1336</fpage><lpage>1343</lpage><pub-id pub-id-type="pmid">26944272</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szentkiralyi</surname><given-names>A</given-names></name><name><surname>Molnar</surname><given-names>MZ</given-names></name><name><surname>Czira</surname><given-names>ME</given-names></name><name><surname>Deak</surname><given-names>G</given-names></name><name><surname>Lindner</surname><given-names>AV</given-names></name><name><surname>Szeifert</surname><given-names>L</given-names></name><name><surname>Torzsa</surname><given-names>P</given-names></name><name><surname>Vamos</surname><given-names>EP</given-names></name><name><surname>Zoller</surname><given-names>R</given-names></name><name><surname>Mucsi</surname><given-names>I</given-names></name><etal/></person-group><article-title>Association between restless legs syndrome and depression in patients with chronic kidney disease</article-title><source>J Psychosom Res</source><year>2009</year><volume>67</volume><fpage>173</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">19616146</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossola</surname><given-names>M</given-names></name><name><surname>Luciani</surname><given-names>G</given-names></name><name><surname>Tazza</surname><given-names>L</given-names></name></person-group><article-title>Fatigue and its correlates in chronic hemodialysis patients</article-title><source>Blood Purif</source><year>2009</year><volume>28</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">19684391</pub-id></element-citation></ref></ref-list></back></article>